AGUETTANT Trademark

Trademark Overview


On Wednesday, November 30, 2022, a trademark application was filed for AGUETTANT with the United States Patent and Trademark Office. The USPTO has given the AGUETTANT trademark a serial number of 97697395. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 9, 2024. This trademark is owned by AGUETTANT SANTE. The AGUETTANT trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medical devices in the nature of delivery systems for pharmaceutical products, namely, prefilled syringes, injection pens and injectable administration devices, containing pharmaceutical preparations for the treatment of transitional bradycardia, hypotension, Parkinson's disease, hypersensitivity, asthmatic attacks, hypocalcemia, edema including as an adjunctive therapy for acute pulmonary edema, nephrotic syndroms, magnesium deficiency, cardiac arrest and transitory atrioventricular heart block or the prevention of cardiac arrest and transitory atrioventricular heart block, ventricular arrhythmias, and including as an adjuvant in surgical anaesthesia, and for prevention and control of pre-eclampsia and eclampsia seizures

Research and Development services for new products in the fields of medical, pharmaceutical and/or biotechnology
aguettant

General Information


Serial Number97697395
Word MarkAGUETTANT
Filing DateWednesday, November 30, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical devices in the nature of delivery systems for pharmaceutical products, namely, prefilled syringes, injection pens and injectable administration devices, containing pharmaceutical preparations for the treatment of transitional bradycardia, hypotension, Parkinson's disease, hypersensitivity, asthmatic attacks, hypocalcemia, edema including as an adjunctive therapy for acute pulmonary edema, nephrotic syndroms, magnesium deficiency, cardiac arrest and transitory atrioventricular heart block or the prevention of cardiac arrest and transitory atrioventricular heart block, ventricular arrhythmias, and including as an adjuvant in surgical anaesthesia, and for prevention and control of pre-eclampsia and eclampsia seizures
Goods and ServicesResearch and Development services for new products in the fields of medical, pharmaceutical and/or biotechnology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 22, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAGUETTANT SANTE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLyon 69007
FR

Trademark Events


Event DateEvent Description
Saturday, December 3, 2022NEW APPLICATION ENTERED
Tuesday, December 6, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, December 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 6, 2023ASSIGNED TO LIE
Monday, February 6, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Saturday, September 9, 2023ASSIGNED TO EXAMINER
Monday, September 11, 2023NON-FINAL ACTION WRITTEN
Monday, September 11, 2023NON-FINAL ACTION E-MAILED
Monday, September 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 10, 2023FINAL REFUSAL WRITTEN
Friday, November 10, 2023FINAL REFUSAL E-MAILED
Friday, November 10, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, July 9, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, July 9, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND